You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CTLA-4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

Not yet recruiting
  • Metastatic Melanoma
  • Advanced Melanoma
  • San Francisco, California
    University of California, San Francisco
Jan 13, 2023

Metastatic Colorectal Cancer Trial in Wuhan (SBRT, Fruquintinib, Cadonilimab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • SBRT, Fruquintinib, Cadonilimab
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023

Metastatic Soft-tissue Sarcoma Trial in United States (Cabozantinib, Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Stanford, California
  • +3 more
Jan 10, 2023

Hepatocellular Carcinoma Trial in Beijing (AK104, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 17, 2022

Peripheral T-cell Lymphoma Trial in Beijing (AK104)

Terminated
  • Peripheral T-cell Lymphoma
  • AK104
  • Beijing, Beiing, China
    Beijing Cancer Hospital
Oct 17, 2022

Health Volunteer Trial in Beijing (Recombinant human CTLA-4-FC fusion protein for injection 1mg/kg, Recombinant human CTLA-4-FC

Recruiting
  • Health Volunteer
  • Recombinant human CTLA-4-FC fusion protein for injection 1mg/kg
  • +9 more
  • Beijing, China
    Peking University People's Hospital
Feb 15, 2022

CTLA4 Haploinsufficency, Chronic Cytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • CTLA4 Haploinsufficency
  • Chronic Cytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Hepatocellular Carcinoma Trial in Hangzhou (AK104 lenvatinib, AK104)

Active, not recruiting
  • Hepatocellular Carcinoma
  • AK104 lenvatinib
  • AK104
  • Hangzhou, Zhejiang, China
    The first affilited hospital zhejiang university school of medci
Oct 17, 2022

NSCLC (Non-small-cell Lung Cancer) Trial in Changchun (Sintilimab, IBI310)

Recruiting
  • NSCLC (Non-small-cell Lung Cancer)
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Sep 21, 2022

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

Recruiting
  • Cancer
  • +6 more
  • Brussels, Belgium
  • +3 more
Jan 30, 2023

Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Trial (SBRT, Cadonilimab)

Not yet recruiting
  • Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
  • (no location specified)
Feb 8, 2023

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Intermediate Stage of Hepatocellular Carcinoma, Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, Tremelimumab (Cohort A

Recruiting
  • Intermediate Stage of Hepatocellular Carcinoma
  • Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Oct 6, 2022

Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland

Not yet recruiting
  • Locally Advanced Thyroid Gland Anaplastic Carcinoma
  • +2 more
  • Chicago, Illinois
  • +1 more
Jul 7, 2022

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

CTLA-4 and LRBA Hereditary Deficiency

Completed
  • CTLA4 Haploinsufficiency
    • Montpellier, France
      Uhmontpellier
    Nov 12, 2021

    SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)

    Not yet recruiting
    • SCLC,Extensive Stage
    • AK104 IV infusion；Chiauranib oral
    • Changchun, Jilin, China
      Jilin Province Cancer Hospital
    Aug 16, 2022

    Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

    Not yet recruiting
    • Castration-Sensitive Prostate Carcinoma
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Feb 8, 2023

    Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

    Recruiting
    • Leptomeningeal Metastasis
    • +2 more
    • intrathecal nivolumab and intrathecal ipilimumab
    • Geneva, Switzerland
    • +2 more
    Dec 18, 2022

    Solid Tumor Trial in China (SI-B003)

    Recruiting
    • Solid Tumor
    • Beijing, Beijing, China
    • +7 more
    Jan 11, 2023

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Nasopharyngeal Cancer
    • Bengbu, Anhui, China
    • +12 more
    Dec 13, 2022

    Hepatocellular Carcinoma Trial in Guangzhou (Cadonilimab, transjugular intrahepatic portosystemic shunt (TIPS))

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Cadonilimab
    • transjugular intrahepatic portosystemic shunt (TIPS)
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 30, 2023

    Cadonilimab in Recurrent or Metastatic Cervical Cancer

    Not yet recruiting
    • Recurrent or Metastatic Cervical Cancer
    • (no location specified)
    Nov 23, 2023

    NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)

    Terminated
    Has Results
    • Non-small Cell Lung Cancer
    • Saint Petersburg, Florida
    • +2 more
    Oct 22, 2022